1. Introduction {#S5}
===============

The majority of victims of major trauma require computed tomographic angiography of the thoracic aorta (CTA-TA) as part of their imaging evaluation.^[@R1]^ CTA-TA requires intravenous access (IVA) for contrast media injection (CMI) at high flow rates.^[@R2]^ Peripheral IVA is favored for this purpose, but is not always achievable.^[@R2]^ In such circumstances, central lines can be used for CMI.^[@R2]^ In instances when central line placement is inexpedient or impossible, an alternative exists: intraosseous needle intravenous access (ION-IVA) (see [Figs 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}). ION-IVA placement is safer and faster than central line placement, with a failure rate of less than 1%.^[@R3]^

A recent clinical review by Baadh et al. calls for imaging physicians to familiarize themselves with the technique of using ION-IVA for CMI.^[@R4]^ There is a substantial body of mid twentieth century literature, predating the advent of computed tomography, reporting the safe use of ION-IVA for CMI during fluoroscopic venography studies.^[@R5]^ Fairly recent data on the safe use of ION-IVA for CMI from animal models has also been published.^[@R6],[@R7]^ However, modern literature reporting the clinical use of ION-IVA for CTA-TA is sparse.^[@R4],[@R8]--[@R10]^ The objective of this study was to retrospectively survey the safety of ION-IVA CMI performed during CTA-TA and to assess the quality of the resultant exams.

2. Materials and methods {#S6}
========================

7401 CTA-TA exams, performed between January 1, 2013 and August 14, 2015, were reviewed to create a CTA-TA database. Written informed consent was waived by the Institutional Review Board due to the retrospective nature of the project and because of the large number of exams included in the database. CTA-TA quality measurements were performed from survey series of 3.0 mm thick images. Attenuation and noise were measured within the ascending aorta and nearby adipose tissue using circular region-of-interests of approximately 100 mm.^[@R2]^ Contrast-to-noise ratio (CNR) for the aorta was derived using the method of Feuchtner et al.^[@R11]^ Other CTA-TA data collected included technical factors such as site of IVA, CMI rate, CMI dose, scanner type, and reconstruction method. Patient data, such as age, sex, weight, height, and chest width, was collected. The institutional adverse event reporting system was queried for all events related to CTA-TA. Complete chart review was performed for all patients who received CTA-TA exams utilizing ION-IVA.

Statistical analyses were performed using open source "R" statistical software version 3.1.1. Scatterplots and correlation coefficients were used to examine adequacy of a linear association between CNR and covariates of interest. The potential of multicollinearity was assessed with the Pearson correlation coefficient. Multiple linear regression models were fitted with two-way interactions. Backward elimination procedure, F-statistic, and adjusted R squared were used to select parsimonious models. Constant variance, normality, and independence were examined.

3. Results {#S7}
==========

17 (\~0.2%) of 7401 of the exams performed during the study period utilized ION-IVA. All ION-exams were performed with EZ-IO needles (Teleflex Medical, Limerick, Pennsylvania, U.S.A.). CMI rates for ION-exams varied between 2.5 and 4.0 ml/s (mean of 3.4 ml/s). CMI dose varied between 80 and 100 ml (mean of 91 ml) of Iohexol 350. Mean attenuation for the ION-exams was 312 HU (SD 88 HU) and mean CNR was 25 (SD 9.9). Assessment of attenuation versus other covariates revealed a strong positive linear association between attenuation and CMI rate (R = 0.58, p-value = 0.014) and a strong negative association between attenuation and chest width (R = −0.53, p-value = 0.028). CNR also exhibited a strong negative linear association with chest width (R = −0.77, p-value\<0.001). ION-exam and patient data is summarized in [Table 1](#T1){ref-type="table"}. Representative images from exemplary ION-exams are presented in [Fig. 2](#F2){ref-type="fig"} (and GIFs 1 and 2 online).

No extravasation events related to CMI via ION-IVA occurred. However, it is interesting to note that two patients received ION-IVA CMI after extravasations related to antecubital IVA (for example see [Fig. 1a](#F1){ref-type="fig"}, GIF 2). A complete review of ION-exam patient records failed to reveal any evidence of ION-IVA related complication. Specifically, there were no reports of ION-IVA placement failure, functional failure, bone marrow aspiration difficulty, damage to the ION-IVA, aborted CTA-TA exam, extravasation, patient discomfort, fracture, infection, fat embolism, bone infarction, or manifestation of compartment syndrome.

4. Discussion {#S8}
=============

The use of ION-IVA for CTA-TA during the study period was rare, occurring in only 17 (0.2%) of the 7401 exams performed. (central lines, in contrast, were utilized in 125). This rarity may reflect trepidation of imaging personnel who were confused by or unfamiliar with ION-IVA. However, the study institution has developed a useful algorithm ([Fig. 3](#F3){ref-type="fig"}) for using ION-IVA for CMI. As this and other algorithms^[@R4]^ are promulgated via the medical literature, training in the use ION-IVA for CTA-TA may become routine. Furthermore, it is promising that in this series no untoward event related to CMI via ION-IVA was observed. As this and similar evidence^[@R4],[@R8]--[@R10]^ related to the safety of ION-IVA for CMI mounts, personnel may be less reluctant to use ION-IVA for this indication.

The mean aortic attenuation observed in the ION-exams was 312 HU, exceeding the mean attenuation of exams in the database performed with antecubital access, which was 271 HU. Due to the small sample size of ION-exams, this result should not be considered significant. The ION-exam data demonstrated statistically significant positive linear associations between aortic attenuation and CMI rate. The implication of this association is that, although the vascular anatomy of bone differs from that of superficial soft tissue, these differences do not limit flow, at least for rates less than 4.0 ml/s. Further study will be necessary to determine if this holds true for higher injection rates (e.g. the 5.0--6.0 ml/s rates recommended for cardiac CT).

Intramedullary bone is rich in pain receptors, and there is both the potential for, and anticipation of, pain during prolonged ION-IVA infusions.^[@R3],[@R12]^ While it is interesting that during this review no reports of ION-IVA related pain were found, it is important to note that all of the patients studied were either experiencing pain associated this their traumatic injuries, the recipients of IV analgesia, or obtunded at the time of CTA-TA acquisition. Consequentially, pain from their ION-IVA infusions may have been masked or simply not recorded. Prophylactic analgesia is recommended when ION-IVA is used for large volume infusions.^[@R3]^

4.1. Limitations and bias {#S9}
-------------------------

This study has notable limitations. It is a single institution observational study that yielded a very small sample size (N = 17). Patients with difficult AC-IVA often suffer from cardiovascular insufficiency, which may have introduced susceptibility bias. Technologist unfamiliarity with ION likely lead to selection bias and may explain the small sample size of this study.

5. Conclusion {#S10}
=============

The data presented herein suggests ION-IVA may be an acceptable alternative route for CMI for CTA-TA when peripheral IVA is unavailable or inexpedient. Prospective studies should be performed to validate this finding.

6. Summary {#S11}
==========

This study investigated the safety and quality of intraosseous needle intravenous access for contrast injection for Computed Tomographic Angiography of the Thoracic Aorta. A retrospective search of a quality and safety database found 17 studies performed in this manner. A control group, comprised of the studies in the database performed with antecubital intravenous access, was used for comparison. The quality metrics of the two groups were similar, with the intraosseous needle group being slightly better. A review of patient and complication records found no evidence of complications related to intraosseous needle use.
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CTA-TA

:   computed tomographic angiography of the thoracic aorta

IVA

:   intravenous access

CMI

:   contrast media injection

*P*-IVA

:   peripheral intravenous access

ION-IVA

:   intraosseous needle intravenous access

ION-exams

:   examinations performed using ION-IVA

CNR

:   contrast-to-noise ratio

![A) MPR image derived from a preliminary scan performed to check intraosseous needle position. B) Thin MIP image derived from a scan showing an intraosseous needle and contrast media within the intramedullary space. C) CPR image showing path of contrast media from right humerus to the right atrium. D) Path of contrast from the left humerus.](nihms862466f1){#F1}

![A) VR image of data from an ION-exam. Note that there is bilateral extravasation from two injection attempts via antecubital IVA. In this case, ION-IVA was used to salvage the study. B) VR image of data from a different ION-exam. Note that in this case the post contrast media saline flush was not adequate and there is residual contrast within the venous system. The image demonstrates the relationship of the intramedullary space to the veins of the upper extremity. C) Volume Rendering of data from a scan of two intraosseous needle sets, one with the trocar in place and the other with the trocar beside the needle. D) Intraosseous needle loaded on a needle driver and ready for insertion.](nihms862466f2){#F2}

![Algorithm to confirm suitability of ION-IVA for CM injection.](nihms862466f3){#F3}

###### 

Data related to CTA-TA exams performed with ION-IVA.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Case\                              Injection\   Contrast\   ION\   kVp   mAs   CTDIvol\   DLP\        Scanner\   A AA\   N AA\   A F\   CNR AA   History   Age   Sex   Body\   Chest\   Disposition
  Number                             Rate\        Media\      site               (mGy)      (mGy\*cm)   Model      (HU)    (HU)    (HU)                                  Mass\   Width\   
                                     (cm/s)       Dose (mL)                                                                                                              Index   (cm)     
  ---------------------------------- ------------ ----------- ------ ----- ----- ---------- ----------- ---------- ------- ------- ------ -------- --------- ----- ----- ------- -------- -------------
  1                                  2.5          100         RH     120   253   17         446         S40        136     18      −52    10       assault   23    M     26      42       expired

  2                                  2.7          100         RH     120   279   23         492         S40        233     16      −112   22       fall      88    F     33      46       rehab

  3                                  3            100         RH     120   202   17         461         S40        250     21      −113   17       MVC       48    F     29      42       home

  4                                  3            100         LT     120   200   16         341         S40        239     18      −109   19       MVC       51    F     30      42       expired

  5                                  3            100         RH     120   185   15         331         S40        308     13      −95    31       assault   23    M     18      33       rehab

  6                                  3.5          80          RH     120   154   13         371         S40        434     11      −91    48       EXP       32    M     17      32       rehab

  7                                  3.2          100         LT     100   130   5          145         Edge       254     12      −83    28       MVC       27    M     20      32       home

  8[a](#TFN2){ref-type="table-fn"}   3.5          100         LH     120   192   16         377         S40        396     20      −88    24       GSW       21    M             35       expired

  9                                  3.5          80          LH     120   206   17         292         S40        299     21      −103   19       fall      40    F     28      45       home

  10                                 3.5          100         LH     120   149   12         345         S40        407     14      −100   36       MVC       26    F     23      29       home

  11                                 3.5          80          LH     100   140   6          118         Edge       367     18      −117   27       fall      47    M     23      31       home

  12                                 3.5          80          RH     120   235   15         370         Edge       260     10      −127   39       MVC       24    M     28      35       home

  13                                 3.5          80          RH     120   197   16         357         S40        235     37      −107   9        MVC       34    M     27      47       home

  14                                 4            80          RH     120   200   16         336         S40        374     23      −96    20       MVC       23    F     35      45       home

  15                                 4            90          LH     120   192   16         396         S40        456     18      −91    30       MVC       27    F     26      37       expired

  16                                 4            100         RH     120   204   17         395         S40        272     20      −108   19       GSW       62    F     29      46       home

  17                                 4            80          RH     100   227   9          201         Edge       381     19      −120   26       GSW       28    M     23      35       home

  mean                               3.41         91                 116   197   14         339                    311     18      −101   25                 37          26      38       

  SD                                 0.46         9.9                7.9   39    4.4        102                    88      6       17     10                 18          5       6        
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: ION = intraosseous needle, CTDIvol = volume computed tomography dose index, DLP = dose length product, HU = Hounsfield units, S40 = Siemens Sensation 40 ERCT, Edge = Siemens Somatom Definition Edge, A = attenuation, AA = ascending aorta, N = noise, F = fat, RH = right humerus, LH = left humerus, LT = left tibia, MVC = motor vehicle collision, EXP = explosion, GSW = gunshot wound, M = male, F = female, CNR = contrast to noise ratio, rehab = rehabilitation facility, SD = standard deviation.

Height and weight data was not recorded for this patient. In all cases the contrast media, Iohexol 350, was injected at room temperature.
